Scientific evidence has demonstrated that NLRP3 over-activation during bowel inflammation could be associated with a breakdown of enteric immune balance, suggesting the involvement of NLRP3 in the pathogenesis of various immune-mediated diseases as IBS [11,13]. This evidence concerns the gene NLRP3 and irritable bowel syndrome.